Blood pressure and cognitive decline in the elderly

Current Opinion in Nephrology and Hypertension

Volumn 8, Issue 3, 1999, Pages 347-351

  Starr, John M ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Royal Victoria Hospital Edinburgh   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; BLOOD PRESSURE REGULATION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; GERIATRIC CARE; HUMAN; HYPERTENSION; HYPOTENSION; INSULIN RESISTANCE; MENTAL CAPACITY; NEUROPSYCHOLOGY; PRIORITY JOURNAL; REVIEW; SOCIAL PROBLEM; SOCIOECONOMICS;

AGED; BLOOD PRESSURE; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LONGITUDINAL STUDIES; NEURODEGENERATIVE DISEASES; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL;

EID: 0032781613     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199905000-00012     Document Type: Review

References (53)

1. Waldstein SR, Manuck SB, Ryan CM, Muldoon MF. Neuropsychological correlates of hypertension: review and methodologic considerations. Psychol Bull 1991; 110:451-468.
2. Dealberto M-J, Sauron B, Derouesne C, Boyer P, Mayeux D, Piette F, et al. Factors associated with low cognitive performance in general practice. Eur Arch Psychiatr Clin Neurosci 1994; 244:53-58.
3. Muldoon MF, Waldstein SR, Jennings JR. Neuropsychological consequences of antihypertensive medication use. Exp Aging Res 1995; 21:353-368.
4. Guo Z, Viitanen M, Winblad B. Clinical correlates of low blood pressure in very old people: the importance of cognitive impairment. J Am Geriatr Soc 1997; 45:701-705.
5. Starr JM, Whalley LJ, Inch S, Shering PA. Blood pressure and cognitive function in healthy old people. J Am Geriatr Soc 1993; 41:753-756.
6. Forette F, Seux M-L, Thijs L, Le Divenah A, Perol M-B, Rigaud A-S, et al. Detection of cerebral aging, an absolute need: predictive value of cognitive status. Eur Neurol 1998; 39 (Suppl. 1):2-6.
7. van Boxtel MPJ, Galliard C, Houx PJ, Buntinx F, Deleeuw PW, Jolles J. Can the blood pressure predict cognitive task performance in a healthy population sample? J Hypertens 1997; 15:1069-1076.
8. Cacciatore F, Abete P, Ferrara N, Paolisso G, Arnato L, Canonico S, et al. The role of blood pressure in cognitive impairment in an elderly population. J Hypertens 1997; 15:135-142.
9. Breteler MMB, Van Swieten JC, Bots ML, Grobbee DE, Claus JJ, Van den Hout JHW, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994; 44:1246-1252.
10. Heckbert SR, Longstreth Jr WT, Psaty BM, Murros KE, Smith NL, Newman AB, et al. The association of antihypertensive agents with MR I white matter findings and with modified mini-mental state examination in older adults. J Am Geriatr Soc 1997; 12:1423-1433. A 'naturalistic' study of hypertensive patients that found that white matter lesions and mental performance were worse in those on calcium antagonists.
11. Palombo V, Scurti R, Muscari A, Puddu GM, Di Lorio A, Zito M, Abate G. Blood pressure and intellectual function in elderly subjects. Age Ageing 1997; 26:91-98.
12. Matsubayashi K, Okumiya K, Wada T, Osaki Y, Fujisawa M, Doi Y, Ozawa T. Postural dysregulation in systolic blood pressure is associated with worsened scoring on neurobehavioral function tests and leukoaraiosis in the older elderly living in a community. Stroke 1997; 28:2169-2173.
13. Fioravanti M, Nacca D, Golfieri B, Lucia P, Cugini P. The relevance of continuous blood pressure monitoring in examining the relationship of memory efficiency with blood pressure characteristics. Physiol Behav 1996; 59:1077-1084.
14. Elias PK, D'Agostino RB, Elias MF, Wolf PA. Blood pressure, hypertension, and age as risk factors for poor cognitive performance. Exp Aging Res 1995; 21:393-417.
15. Elias MF, D'Agostino RB, Elias PK, Wolf PA. Neuropsychological test performance, cognitive functioning, blood pressure, and age: the Framingham Heart Study. Exp Aging Res 1995; 21:369-391.
16. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998; 31:780-786.
17. Elias PK, Elias MF, D'Agostino RB, Cupples LA, Wilson PW, Silbershatz H, Wolf PA. NIDDM and blood pressure as risk factors for poor cognitive performance: the Framingham Study. Diabetes Care 1997; 20:1388-1395. Framingham data suggesting that an interaction between hypertension and type 2 diabetes impairs cognition.
18. Starr JM, Deary IJ, Inch S, Cross S, MacLennan WJ. Blood pressure and cognitive decline in healthy old people. J Hum Hypertens 1997; 11:777-781. One of the few longitudinal studies in the elderly in which both blood pressure and mental abilities were measured on more than one occasion.
19. Deary IJ, Starr JM, MacLennan WJ. Fluid intelligence, memory and blood pressure in cognitive aging: personality and individual differences 1998; 25:605-619.
20. Zhu L, Viitanen M, Guo Z, Winblad B, Fratiglioni L. Blood pressure reduction, cardiovascular diseases, and cognitive decline in the Mini-Mental State Examination in a community population of normal very old people: a three-year follow-up. J Clin Epidemiol 1998; 51:385-391.
21. Prince M, Lewis G, Bird A, Blizard R, Mann A. A longitudinal study of factors predicting change in cognitive test scores over time, in an older hypertensive population. Psychol Med 1996: 26:555-568.
22. Kalra L, Jackson SH, Swift CG. Effect of antihypertensive treatment on psychomotor performance in the elderly. J Hum Hypertens 1993; 3:285-290.
23. Starr JM, Whalley LJ, Deary IJ. The effects of antihypertensive treatment on cognitive function: results from the HOPE study. J Am Geriatr Soc 1996; 44:411-415.
24. Meyer JS, Takashima S, Obara K, Muramatsu K, Mortel KF. Longitudinal outcome following treatment of hypertension among patients with ischemic vascular dementia. Hypertens Res Clin Exp 1994; 17 (Suppl. 1):S89-96.
25. Hogan DB, Ebly EM, Rockwood K. Weight, blood pressure, osmolarity, and glucose levels across various stages of Alzheimer's disease and vascular dementia. Dementia Geriatr Cogn Disord 1997; 8:147-151.
26. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L, Nilsson L, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347:1141-1145.
27. Elmstahl S, Rosen I. Postural hypotension and EEG variables predict cognitive decline: results from a 5-year follow-up of healthy elderly women. Dementia Geriatr Cogn Disord 1997; 8:180-187. A small study that suggests that blood pressure dysregulation and EEG changes may predict subsequent cognitive decline.
28. Vanhanen H, Thijs L, Birkenhager W, Tilvis R, Sarti C, Tuomilehto J, et al. Associations of orthostatic blood pressure fall in older patients with isolated systolic hypertension. Syst-Eur Investigators. J Hypertens 1996; 14:943- 949.
29. Starr JM, Whalley LJ. ACE inhibitors: central actions. New York: Raven Press; 1994.
30. Strachan MWJ, Ewing FME, Deary IJ, Frier BM. Is type II diabetes associated with an increased risk of cognitive dysfunction? Diabetes Care 1997; 20:438-445.
31. Vanhanen M, Koivisto K, Kuusisto J, Mykkanen L, Helkala E-L, Hanninen T, Reikkinen P, et al. Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care 1998; 21:398-402.
32. Araki Y, Nomura M, Tanaka H, Yamamoto H, Yamamoto T, Tsukaguchi I, Nakamura H. MRI of the brain in diabetes mellitus. Neuroradiology 1994; 36:101-103.
33. Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, et al. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ 1997; 315:1045-1049.
34. Phillips DI, Barker DJ. Association between low birthweight and high resting pulse in adult life: is the sympathetic nervous system involved in programming the insulin resistance syndrome? Diabetic Med 1997; 14:673-677. This paper links early life experiences with insulin resistance and altered sympathetic nervous system regulation providing a paradigm to explain findings in many other studies.
35. Vanhala M, Vanhala P, Kumpusalo E, Halonen P, Takala J. Relation between obesity from childhood to adulthood and the metabolic syndrome: population based study. BMJ 1998; 317:319.
36. Kitagawa T, Owada M, Urakami T, Yamauchi K. Increased incidence of non- insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat. Clin Pediatr 1998; 37:111-115.
37. Sung BH, Wilson MF, Izzo Jr JL, Ramirez L, Dandona P. Moderately obese, insulin-resistant women exhibit abnormal vascular reactivity to stress. Hypertension 1997; 30:848-853.
38. Moan A, Eide IK, Kjeldsen SE. Metabolic and adrenergic characteristics of young men with insulin resistance. Blood Pressure Supplement 1996; 1:30-37.
39. Keltikangas-Jarvinen L, Ravaja N, Raikkonen K, Lyytinen H. Insulin resistance syndrome and autonomically mediated physiological responses to experimentally induced mental stress in adolescent boys. Metab Clin Exp 1996; 45:614-621.
40. Shapiro DJL, Goldstein IB. Daily mood states and ambulatory blood pressure. Psychophysiology 1997; 34:399-405.
41. Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey. I. Epidemiologic Follow-up Study. Arch Family Med 1997; 6:43-49.
42. Raikkonen K, Keltikangas-Jarvinen L, Adlercreutz H, Hautanen A. Psychosocial stress and the insulin resistance syndrome. Metab Clin Exp 1996; 45:1533-1538.
43. Keltikangas-Jarvinen L, Raikkonen K, Hautanen A, Adlercreutz H. Vital exhaustion, anger expression, and pituitary and adrenocortical hormones: implications for the insulin resistance syndrome. Arterioscler Thromb Vasc Biol 1996; 16:275-280.
44. O'Brien JT. The 'glucocorticoid cascade' hypothesis in man. Br J Psychiatr 1997; 170:199-201.
45. Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NPV, et al. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nature Neurosci 1998; 1:69-73. The first prospective human evidence strongly supporting the 'glucocorticoid cascade' hypothesis of the effects of stress on the hippocampus.
46. Davey Smith G, Hart C. Insulin resistance syndrome and childhood social conditions. Lancet 1997; 349:284-285.
47. Starr JM, Inch S, Cross S, MacLennan WJ, Deary IJ. Blood pressure and ageing: longitudinal cohort study. BMJ 1998; 317:513-514.
48. Berkman LF, Macintyre S. The measurement of social class in health studies: old measures and new formulations. IARC Scientific Publications 1997; 138:51-64.
49. Starr JM, Deary IJ, Inch S, Cross S, MacLennan WJ. Age-associated cognitive decline in healthy old people. Age Ageing 1997; 26:295-300.
50. Marmot MG, Shipley MJ. Do socioeconomic differences in mortality persist after retirement? 25 year follow up of civil servants from the first Whitehall study. BMJ 1996; 313:1177-1180.
51. Brunner EJ, Marmot MG, Nanchahal K, Shipley MJ, Stansfeld SA, Juneja M, Alberti KG. Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabelologia 1997; 40:1341-1349.
52. Marmot MG, Bosma H, Hemingway H, Brunner E, Stansfeld S. Contribution of job control and other risk factors to social variations in coronary heart disease incidence. Lancet 1997; 350:235-239.
53. Stansfeld SA, Bosma H, Hemingway H, Marmot MG. Psychosocial work characteristics and social support as predictors of SF-36 health functioning: the Whitehall II study. Psychosom Med 1998; 60:247-255.